What's the deal? InnoSer International has acquired all assets of Vivo Science, a GLP-certified preclinical contract research organisation in Gronau, Germany. The acquisition was finalised on 4 August 2026 and became effective on 1 August, adding a GLP-certified testing site to InnoSer's network in Belgium and the Netherlands. Financial terms were not disclosed.
What changes? Vivo Science's scientific and technical teams, GLP certification and client relationships will remain in place as the site operates as InnoSer Deutschland GmbH. The acquisition adds immunology, toxicology and viral-safety expertise, extending InnoSer's ability to support sponsors from early feasibility work through GLP-compliant, submission-ready data.
Why it matters. The deal gives InnoSer a three-site footprint across Belgium, the Netherlands and Germany and advances its strategy of selective acquisitions alongside organic growth. Vivo Science has specialised in immunology, toxicology and viral-safety testing since the early 2000s, with GLP certification obtained in 2004 and GMP status in 2007.
Read more: InnoSer
Image credit: Generated with Gemini
23
64
Get AI-powered insights
Ask anything about this entity
Suggested questions:
All answers are AI generated. They may be incomplete or incorrect.